Option Care Health, Inc. (OPCH) is a services-home health care services company. Piotroski F-Score 5/9. 15 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-07-29 from OPCH's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
eight-variable model; a screen for earnings-quality review, not an accusation
A plain-English read on OPCH plus an auto-SWOT — built from OPCH's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate OPCH using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Duquesne Family Office (Druckenmiller) | $50K | 1.5% of portfolio |
Projected from OPCH's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment OPCH files its announcement.
OPCH has sold off after 5 of its last 8 earnings reports.
Large earnings reactions have been common.
OPCH has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+19.7% and -25.5%).
A more typical earnings reaction has been approximately ±8.1%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-04-30 | -25.5% |
| 2026-02-24 | -6.9% |
| 2026-01-12 | +9.3% |
| 2025-10-30 | -9.2% |
| 2025-07-30 | -2.6% |
| 2025-04-29 | -2.0% |
| 2025-02-26 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +1.7% |
| 2025-01-13 | +19.7% |
| SULLIVAN TIMOTHY PDirector | BUY | $500K | view → |
| KRAEMER HARRY M JANSEN JRDirector | BUY | $784K | view → |
| RADEMACHER JOHN CHARLESChief Executive Officer | BUY | $265K | view → |
| Sethna MeenalChief Financial Officer | BUY | $327K | view → |
| Bavaro MichaelChief Human Resources Officer | SELL | $198K | view → |
| Pate R CarterDirector | SELL | $971K | view → |